Navigation Links
J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
Date:11/12/2008

Venter Shares Award with James D. Watson, Marilyn & James Simons and Sherry Lansing at Gala New York City Event

ROCKVILLE, Md., Nov. 12 /PRNewswire-USNewswire/ -- J. Craig Venter, Ph.D., Founder and President of the J. Craig Venter Institute (JCVI), was awarded the Double Helix Medal from Cold Spring Harbor Laboratory (CSHL) on November 6th at a gala event in New York City.

Dr. Venter received the Double Helix Medal along with Dr. James D. Watson for making each of their individual genome sequences available for scientific use on the Internet and for promoting awareness of the public health advantages of "personalized genomes."

According to Dr. Bruce Stillman, CSHL President, "The Double Helix Medals recognize individuals who have dedicated their lives to raising the awareness of the importance of genetics research for improving the health of people everywhere." Inaugurated in 2006, the medal is named for the iconic "winding-staircase" structure of the DNA molecule, discovered by Dr. Watson along with Dr. Francis Crick in 1953.

In 2007 Dr. Venter and his team published the first diploid genome, which was his genome and represents both sets of chromosomes inherited from each of his parents. That publication was the first human genome publication since the first sequence and analysis of the human genome published in Science in 2001 by Dr. Venter and colleagues at Celera Genomics. The publicly funded genome project also published their version of the human genome at the same time in the journal Nature.

Dr. Venter and his team are continuing to analyze his genome and are planning to sequence and analyze hundreds to thousands of genomes over the next decade. He has advocated the public release of individual genomes with the view that a growing database in which scientists can compare DNA profiles with health histories and traits will help them understand in greater detail the impact of genetics upon human health. Dr. Venter and his teams have published the sequences of more than 50 genomes, and through the Sorcerer II Expedition have more added more than 20 million new genes to the public databases.

Dr. Watson is Chancellor Emeritus of Cold Spring Harbor Laboratory and won a Nobel Prize along with Francis Crick in 1962 for their description of the structure of DNA. Dr. Watson is credited for developing the modern vision for Cold Spring Harbor Laboratory.

About the J. Craig Venter Institute

The JCVI is a not-for-profit research institute in Rockville, MD and La Jolla, CA dedicated to the advancement of the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policymakers. Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 400 scientists and staff with expertise in human and evolutionary biology, genetics, bioinformatics/informatics, information technology, high-throughput DNA sequencing, genomic and environmental policy research, and public education in science and science policy. The legacy organizations of the JCVI are: The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), the Joint Technology Center (JTC), and the J. Craig Venter Science Foundation. The JCVI is a 501(c)(3) organization. For additional information, please visit http://www.JCVI.org.


'/>"/>
SOURCE J. Craig Venter Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
2. Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist
3. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
4. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
5. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
6. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
9. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):